Skip to main content
Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 20.31
Day High 21.56
Open:21.32
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Exelixis, Inc. is a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer. Exelixis is focusing its development and commercialization efforts primarily on COMETRIQ' (cabozantinib), its wholly-owned inhibitor of multiple receptor tyrosine kinases. Another Exelixis-discovered compound, cobimetinib, a selective inhibitor of MEK, is being evaluated by Roche and Genentech (a member of the Roche Group) in a broad development program under a collaboration with Exelixis.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Exelixis to Release First Quarter 2019 Financial Results on Wednesday, May 1, 2019
BusinessWire - Wed Apr 17, 3:05PM CDT
BusinessWire - CMTX
Wed Apr 17, 3:05PM CDT
Exelixis, Inc. (NASDAQ: EXEL) announced today that its first quarter 2019 financial results will be released on Wednesday, May 1, 2019 after the markets close. At 5:00 p.m. EDT / 2:00 p.m. PDT, Exelixis management will host a conference call and webcast to discuss the results and provide a general business update. Access to the event is available via the Internet from the company's website.
Exelixis to Present at the 18th Annual Needham Healthcare Conference on April 10, 2019
BusinessWire - Fri Apr 5, 3:05PM CDT
BusinessWire - CMTX
Fri Apr 5, 3:05PM CDT
Exelixis, Inc. (NASDAQ: EXEL) today announced that Christopher J. Senner, the company's Executive Vice President and Chief Financial Officer, and Andrew R. Peters, the company's Vice President, Strategy, will provide an overview of the company at the 18th Annual Needham Healthcare Conference taking place on Wednesday, April 10, 2019 in New York, NY. The Exelixis presentation is scheduled that day for 4:10 PM EDT / 1:10 PM PDT.
Watch for Exelixis Inc to Potentially Pullback After Gaining 1.20% Yesterday
Comtex SmarTrend(R) - Fri Mar 29, 12:27PM CDT
Comtex SmarTrend(R) - CMTX
Fri Mar 29, 12:27PM CDT
Exelixis Inc (NASDAQ:EXEL) traded in a range yesterday that spanned from a low of $23.66 to a high of $24.03. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $23.73 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 20.31 +2.90% increase
on 04/18/19
Period Open:24.14
Price movement based on the high, low and last over the given period.
25.20 -17.06% decrease
on 04/03/19
-3.24 (-13.42%) decrease
since 03/18/19
3-Month 20.31 +2.90% increase
on 04/18/19
Period Open:22.65
Price movement based on the high, low and last over the given period.
25.31 -17.42% decrease
on 03/18/19
-1.75 (-7.73%) decrease
since 01/18/19
52-Week 13.42 +55.74% increase
on 10/29/18
Period Open:21.42
Price movement based on the high, low and last over the given period.
25.31 -17.42% decrease
on 03/18/19
-0.52 (-2.43%) decrease
since 04/18/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).